PharmaVoice

JANUARY 6, 2025

How regulators could hit PBMs from multiple sides in the coming year.

126

126

PharmaTimes

JANUARY 6, 2025

IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer

Patients 106

Patients 106

pharmaphorum

JANUARY 6, 2025

Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.

FDA 102

FDA 102

MedCity News

JANUARY 6, 2025

Families USA led a letter urging the new Congress, which was sworn in on Jan. 3, to protect Medicaid. The post Over 300 Organizations Call on New Congress to Safeguard and Strengthen Medicaid appeared first on MedCity News.

99

99

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

PharmaTimes

JANUARY 6, 2025

EpiSwitch PSE shows promise in reducing unnecessary procedures

92

92

Pharmaceutical Commerce

JANUARY 6, 2025

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), provides a peek into what the association has set out to accomplish.

Prescription 87

Prescription Pharma 87

pharmaphorum

JANUARY 6, 2025

US biotech NeOnc Technologies has applied to list on the Nasdaq as it advances a portfolio of drugs to treat diseases affecting the CNS.

80

80

PharmaVoice

JANUARY 6, 2025

A first-in-class pain med and blockbusters with new indications are just a few of the possible approvals to keep an eye on in the new year.

FDA 60

FDA 60

pharmaphorum

JANUARY 6, 2025

MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk.

Manufacturing 79

Manufacturing 79

European Pharmaceutical Review

JANUARY 6, 2025

Roche and Innovent Biologics, Inc. have agreed to collaborate to advance development of an innovative DLL3-targeted antibody drug conjugate (ADC) candidate. Innovent shared that this collaboration focuses on advancing treatment options in advanced small cell lung cancer. Innovent will receive an upfront payment of $80 million. The biopharmaceutical company is eligible for up to $1 billion in milestone payments and certain royalties on net sales.

Safety 52

Safety Manufacturing Medicine Sales 52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

pharmaphorum

JANUARY 6, 2025

More community hubs and changes to the NHS App are at the core of the UK government's new elective reform plan.

Government 77

Government 77

Pharmaceutical Commerce

JANUARY 6, 2025

The moveone that meets industry standardsconfirms the Cryoport companys commitment to providing quality and safety in the cold chain solutions space.

Safety 59

Safety FDA 59

pharmaphorum

JANUARY 6, 2025

The NHS is dealing with a major rise in influenza cases, with the number of hospitalised patients quadrupling to around 5,000 ahead of the New Year.

Patients 65

Patients 65

Pharmaceutical Commerce

JANUARY 6, 2025

The latest news for pharma industry insiders.

Pharma 59

Pharma 59

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

Pharmacy Times

JANUARY 6, 2025

The patient was hospitalized after exposure to an infected backyard flock.

Patients 56

Patients 56

PharmExec

JANUARY 6, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52

FDA 52

Pharmaceutical Technology

JANUARY 6, 2025

The US FDA has granted ODD to NMD Pharmas oral lead development programme, NMD670, designed to treat Charcot-Marie-Tooth disease (CMT).

FDA 52

FDA Pharma Leads 52

PharmExec

JANUARY 6, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52

FDA 52

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Technology

JANUARY 6, 2025

Orbis Medicines has raised 90m ($94m) in Series A funding to advance the development of its next-generation orally dosable macrocycle drugs.

Medicine 52

Medicine 52

PharmExec

JANUARY 6, 2025

Data from the Phase III trial program found that AXS-05 demonstrated statistically significant efficacy in treating Alzheimer disease agitation.

52

52

PharmaTech

JANUARY 6, 2025

Pharmaceutical Technology chats about continuous processes and regulatory considerations for processing equipment with Christian Dunne from ChargePoint Technology.

Pharmaceutical 52

Pharmaceutical 52

PharmExec

JANUARY 6, 2025

John Hood, CEO, Endeavor BioMedicines discusses a potential timeline on availability of ENV-101 for patients with IPF and further validation of the treatment's safety profile.

Safety 52

Safety Patients 52

Advertiser: ZoomInfo

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

Prospecting

Pharmaceutical Technology

JANUARY 6, 2025

Amgens bispecific T-cell engager (BiTE) led to an ORR of 41% in patients with extensive-stage small cell lung cancer.

Patients 52

Patients 52

PharmExec

JANUARY 6, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Technology

JANUARY 6, 2025

The decision follows a positive recommendation received from the Committee for Medicinal Products for Human Use (CHMP) in November 2024.

Medicine 52

Medicine 52

PharmExec

JANUARY 6, 2025

In the race to bolster pipelines and drive growth, biopharma manufacturers are reexamining traditional practices and reimagining market research protocols.

Biopharma 52

Biopharma Manufacturing Marketing 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

JANUARY 6, 2025

The China NMPA has approved GSKs Nucala (mepolizumab) as an add-on treatment along with intranasal corticosteroids to treat CRSwNP.

52

52

PharmExec

JANUARY 6, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Technology

JANUARY 6, 2025

The Abu Dhabi Stem Cells Center (ADSCC) has developed clinical-grade induced pluripotent stem cells (iPSCs) that meet GMP protocols.

52

52

PharmExec

JANUARY 6, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Management 52

Management Pharma 52

Advertiser: ZoomInfo

Sales and marketing leaders have reached a tipping point when it comes to using intent data — and they’re not looking back. More than half of all B2B marketers are already using intent data to increase sales, and Gartner predicts this figure will grow to 70 percent. The reason is clear: intent can provide you with massive amounts of data that reveal sales opportunities earlier than ever before.

Sales